An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain
J Kutzsche, GA Guzman, A Willuweit… - British journal of …, 2024 - Wiley Online Library
Abstract Background and Purpose Neuropathic pain affects up to 10% of the global
population and is caused by an injury or a disease affecting the somatosensory, peripheral …
population and is caused by an injury or a disease affecting the somatosensory, peripheral …